JOHN P BRANCACCIO Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for JOHN P BRANCACCIO.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of JOHN P BRANCACCIO. JOHN P BRANCACCIO is a Director in Tamir Biotechnology, Inc. ($ACEL.OB) and a Director in Trovagene, Inc. ($XNOM.OB) and a Director in SYNERGY PHARMACEUTICALS, INC. ($SGYP) and a Director in ContraVir Pharmaceuticals, Inc. ($CTRV).
Address: C/O ALFACELL CORPORATION 225 BELLEVILLE AVENUE BLOOMFIELD 07003 NJ
Companies in which JOHN P BRANCACCIO is an Insider
Cardiff Oncology, Inc.
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of JOHN P BRANCACCIO: Director
Holdings: 12,260 shares
Latest Transaction: Mar 22 2021
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Hepion Pharmaceuticals, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of JOHN P BRANCACCIO: Director
Holdings: 0 shares
Current Value: $0
Latest Transaction: Aug 21 2020
$HEPA Market Capitalization: $85.72M
$HEPA Previous Close: $1.40
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
SYNERGY PHARMACEUTICALS LLC
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of JOHN P BRANCACCIO: Director
Holdings: 130,467 shares
Current Value: $798,458
Latest Transaction: Jul 06 2018
$SGYP Market Capitalization: $1.11B
$SGYP Previous Close: $6.12
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
TAMIR BIOTECHNOLOGY, INC.
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of JOHN P BRANCACCIO: Director
Holdings: 4,000 shares
Latest Transaction: Feb 12 2007
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of JOHN P BRANCACCIO
Sentiment: All, XNOM.OB, HEPA, SGYP, ACEL.OB
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 22 2021 | XNOM.OB | Cardiff Oncology, ... | BRANCACCIO JOHN P | Director | Buy | P | 10.95 | 3,000 | 32,850 | 12,260 | 9.3 K to 12.3 K (+32.40 %) |
| Aug 21 2020 | CTRV | Hepion Pharmaceuti ... | BRANCACCIO JOHN P | Director | Option Exercise | A | 3.72 | 30,000 | 111,600 | 91,332 | |
| Jun 19 2020 | XNOM.OB | Cardiff Oncology, ... | BRANCACCIO JOHN P | Director | Option Exercise | A | 2.60 | 28,858 | 75,031 | 76,517 | |
| May 18 2020 | XNOM.OB | Cardiff Oncology, ... | BRANCACCIO JOHN P | Director | Buy | P | 1.43 | 6,993 | 10,000 | 9,260 | 2.3 K to 9.3 K (+308.47 %) |
| Apr 07 2020 | CTRV | Hepion Pharmaceuti ... | BRANCACCIO JOHN P | Director | Option Exercise | A | 1.63 | 60,000 | 97,800 | 61,275 | |
| Jul 25 2019 | CTRV | Hepion Pharmaceuti ... | BRANCACCIO JOHN P | Director | Option Exercise | A | 3.24 | 970 | 3,143 | 1,275 | |
| Jun 24 2019 | XNOM.OB | Trovagene, Inc. | BRANCACCIO JOHN P | Director | Option Exercise | A | 2.48 | 44,734 | 110,940 | 47,806 |